| Megan Cacciamani, CRNA | |
|
1200 Old York Rd, Abington, PA 19001-3720 | |
| (215) 481-2000 | |
| Not Available |
| Full Name | Megan Cacciamani |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 4 Years |
| Location | 1200 Old York Rd, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356939276 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN650266 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abington Memorial Hospital | Abington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Anesthesia Services Pc | 3173437613 | 371 |
News Archive
Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal.
Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base).
The July 2012 issue of Health Affairs, published Monday, examines the impact of PEPFAR, focusing on "the origins of the program; the lessons learned from implementation; the successes achieved in terms of human health and well-being; and the opportunities that now exist to lay the groundwork for an 'AIDS-free generation,'" the Health Affairs Blog reports, noting, "The new Health Affairs issue will be discussed Tuesday morning at a Washington, D.C., briefing."
MAXIMUS, a leading provider of government services worldwide, announced today that Dr. John F. Boyer, Chairman of the MAXIMUS Foundation and Chairman of MAXIMUS Federal Services, will receive a 2013 Ripple of Hope Award from the Robert F. Kennedy Center for Justice and Human Rights, tonight, December 11, at the New York Hilton in Manhattan.
Children's Hospital Los Angeles and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA's first NGS panel designed to target biomarkers associated with childhood cancers.
› Verified 4 days ago
| Entity Name | United Anesthesia Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053366062 PECOS PAC ID: 3173437613 Enrollment ID: O20031118000620 |
News Archive
Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal.
Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base).
The July 2012 issue of Health Affairs, published Monday, examines the impact of PEPFAR, focusing on "the origins of the program; the lessons learned from implementation; the successes achieved in terms of human health and well-being; and the opportunities that now exist to lay the groundwork for an 'AIDS-free generation,'" the Health Affairs Blog reports, noting, "The new Health Affairs issue will be discussed Tuesday morning at a Washington, D.C., briefing."
MAXIMUS, a leading provider of government services worldwide, announced today that Dr. John F. Boyer, Chairman of the MAXIMUS Foundation and Chairman of MAXIMUS Federal Services, will receive a 2013 Ripple of Hope Award from the Robert F. Kennedy Center for Justice and Human Rights, tonight, December 11, at the New York Hilton in Manhattan.
Children's Hospital Los Angeles and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA's first NGS panel designed to target biomarkers associated with childhood cancers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Cacciamani, CRNA Po Box 828962, Philadelphia, PA 19182-8962 Ph: () - | Megan Cacciamani, CRNA 1200 Old York Rd, Abington, PA 19001-3720 Ph: (215) 481-2000 |
News Archive
Detecting dangerous blood clots, which can cause life-threatening conditions such as strokes and heart attacks, leading causes of death for men and women in the U.S., has been a coveted and elusive goal.
Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base).
The July 2012 issue of Health Affairs, published Monday, examines the impact of PEPFAR, focusing on "the origins of the program; the lessons learned from implementation; the successes achieved in terms of human health and well-being; and the opportunities that now exist to lay the groundwork for an 'AIDS-free generation,'" the Health Affairs Blog reports, noting, "The new Health Affairs issue will be discussed Tuesday morning at a Washington, D.C., briefing."
MAXIMUS, a leading provider of government services worldwide, announced today that Dr. John F. Boyer, Chairman of the MAXIMUS Foundation and Chairman of MAXIMUS Federal Services, will receive a 2013 Ripple of Hope Award from the Robert F. Kennedy Center for Justice and Human Rights, tonight, December 11, at the New York Hilton in Manhattan.
Children's Hospital Los Angeles and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA's first NGS panel designed to target biomarkers associated with childhood cancers.
› Verified 4 days ago
Irene A. Ahorlu, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Rachel Landgraf, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Paul Douglass, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Gregory Olyansky, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Rachel Yashin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2336 | |
Lisamarie Meagher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Martin J Nolan, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 |